EDGAR Filing Documents for 0001725160-22-000107

Form CORRESP - Correspondence:

SEC Accession No. 0001725160-22-000107

Filing Date

2022-05-26

Accepted

2022-05-26 16:04:13

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	CORRESP	38571
2		image_0.jpg	GRAPHIC	5180
	Complete submission text file	0001725160-22-000107.txt		46867

Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018

Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791

Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations